NIH budgets $71M to study rare diseases
The NIH is spending $71 million to launch a host of new studies into rare diseases. Some of those studies will test specific therapies while others will look at the causes of the diseases so that new treatments can be developed. What they discover will be kept by the University of South Florida in Tampa as a way to encourage broader collaboration among the groups studying these ailments.
- read the Wall Street Journal report for more
More stories about National Institutes of Health
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
